B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co

Joint marketing of CytoSorb® with B. Braun’s newest OMNI® blood purification platform will offer greater access of this advanced treatment of deadly inflammation to critically ill patients. MELSUNGEN, Germany and MONMOUTH JUNCTION, N.J., March 2, 2021 /PRNewswire/ — B. Braun Avitum AG, a leading manufacturer of medical devices and pharmaceutical products and services and CytoSorbents Corporation […]

Digital Workplace for B. Braun

Canon Medical Systems Europe Partners with Athletic Bilbao FC

In this image released on Tuesday, March 2, 2021, the CytoSorb® adsorber is used in critical care for the extracorporeal removal of cytokines and inflammatory mediators from the bloodstream. B. Braun Avitum

B. Braun Aesculap - SPINEMarketGroup

Advanced Wound Management Market Size, Demand & Forecast

Global Oncology

新闻详情页-B. Braun Group

Stock Market News 2021-03-02

Company

ctso-20201231x10k001.jpg

Apheresis Machines Market 2021: Comprehensive Study Explores